RESUMO
Cervical carcinoma extending to endometrium, and even more, to myometrium is very rare. At the present time there are only 28 reported cases in the literature, and 31 as primary of endometrium. The diagnosis of this condition requires strict histological criteria. The prognosis is bad. Surgery continues as the main therapeutic resource; the adjunt radiotherapy does not improve survival, and experience with chemiotherapy is limited.
Assuntos
Neoplasias do Endométrio/patologia , Miométrio/patologia , Neoplasias do Colo do Útero/patologia , Neoplasias do Endométrio/cirurgia , Feminino , Humanos , Histerectomia , Pessoa de Meia-Idade , Miométrio/cirurgia , Invasividade Neoplásica , Neoplasias do Colo do Útero/cirurgiaRESUMO
This is a retrospective review of 63 patients with diagnosis of microinvasive cervical carcinoma. Diagnostic methodology included etiology, colposcopy, biopsy and cervical conization. Study parameters were: age, symptomatology, type of treatment and survival. The treatment to be established was chosen according to adverse prognostic factors, such as invasion depth, lymphovascular permeation, invasion pattern. The patients with an invasion depth up to 1 mm (IA1, FIGO) may be conservatively treated by cervical conization, if fertility is to be kept; there is risk of metastasis or recurrence. The patients with invasion of 1 to 5 mm (IA2, FIGO) may have a greater risk of recurrence and lymph node disease; the treatment should be individualized. There are no specific colposcopic data about microcarcinoma, and because of that, diagnostic precision is not high; however, colposcopy shows the adequate site for biopsy sampling, identifies vaginal extension areas and may influence the treatment.